会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Method for Detection of Hepatitus B Virus
    • 乙肝病毒检测方法
    • US20090017443A1
    • 2009-01-15
    • US11596663
    • 2005-05-19
    • Chiharu OhueNoboru MakiTatsuji Kimura
    • Chiharu OhueNoboru MakiTatsuji Kimura
    • C12Q1/70
    • G01N33/5761
    • To provide a method for detection or quantification of hepatitis B virus (HBV) antigens in serum and a simple and highly user-friendly method for sample treatment for use in the detection or quantification thereof. The method for treatment of a sample containing hepatitis B virus (HBV) is characterized in that release of HBV antigens and disruption of antibodies that bind to HBV antigens are carried out by treating a sample containing HBV with a treatment agent containing (1) an acidifying agent and (2) a protein denaturant or an amphoteric surfactant or cationic surfactant having an alkyl group and a tertiary amine or a quaternary ammonium salt within a molecule.
    • 提供血清中乙型肝炎病毒(HBV)抗原的检测或定量的方法,以及用于检测或定量的用于样品处理的简单且高度用户友好的方法。 用于治疗含有乙型肝炎病毒(HBV)的样品的方法的特征在于通过用含有(1)酸化的处理剂处理含有HBV的样品来进行HBV抗原的释放和与HBV抗原结合的抗体的破坏 试剂和(2)分子内具有烷基和叔胺或季铵盐的蛋白质变性剂或两性表面活性剂或阳离子表面活性剂。
    • 4. 发明申请
    • METHOD FOR DETECTION OF HEPATITIS B VIRUS
    • 检测乙型肝炎病毒的方法
    • US20100291546A1
    • 2010-11-18
    • US12828209
    • 2010-06-30
    • Chiharu OhueNoboru MakiTatsuji Kimura
    • Chiharu OhueNoboru MakiTatsuji Kimura
    • C12Q1/70C12N7/00
    • G01N33/5761
    • To provide a method for detection or quantification of hepatitis B virus (HBV) antigens in serum and a simple and highly user-friendly method for sample treatment for use in the detection or quantification thereof. The method for treatment of a sample containing hepatitis B virus (HBV) is characterized in that release of HBV antigens and disruption of antibodies that bind to HBV antigens are carried out by treating a sample containing HBV with a treatment agent containing (1) an acidifying agent and (2) a protein denaturant or an amphoteric surfactant or cationic surfactant having an alkyl group and a tertiary amine or a quaternary ammonium salt within a molecule.
    • 提供血清中乙型肝炎病毒(HBV)抗原的检测或定量的方法,以及用于检测或定量的用于样品处理的简单且高度用户友好的方法。 用于治疗含有乙型肝炎病毒(HBV)的样品的方法的特征在于通过用含有(1)酸化的处理剂处理含有HBV的样品来进行HBV抗原的释放和与HBV抗原结合的抗体的破坏 试剂和(2)分子内具有烷基和叔胺或季铵盐的蛋白质变性剂或两性表面活性剂或阳离子表面活性剂。
    • 5. 发明申请
    • HCV GENE
    • HCV基因
    • US20100173298A1
    • 2010-07-08
    • US12597692
    • 2008-04-28
    • Kenichi MoriNoboru MakiHiromi FukaiChiharu Ohue
    • Kenichi MoriNoboru MakiHiromi FukaiChiharu Ohue
    • C12Q1/68C07H21/04C07K14/005C07H21/02C12N15/63C12N5/071C12N7/00
    • G01N33/5008C07K14/005C12N15/86C12N2770/24222C12N2770/24243C12Q1/707G01N33/5767G01N2333/186G01N2500/00
    • The present invention provides a hepatitis C virus gene, a replicon RNA derived from the gene, a replicon-replicating cell into which the replicon RNA is introduced, and a method for screening a drug using the replicon-replicating cell. By introducing a replicon RNA comprising (A) a polynucleotide having the nucleic acid sequence shown in SEQ ID NO: 5; (B) a polynucleotide having the nucleic acid sequence shown in SEQ ID NO: 7; (C) a polynucleotide coding for a polypeptide having the amino acid sequence shown in SEQ ID NO: 6; (D) a polynucleotide coding for a polypeptide having the amino acid sequence shown in SEQ ID NO: 8; or (E) a polynucleotide having a nucleic acid sequence having a homology of not less than 90% with the nucleic acid sequence shown in SEQ ID NO: 5 or SEQ ID NO: 7; or a replicon RNA of the genotype 1b comprising nucleotides coding for the 1804th amino acid leucine and the 1966th amino acid lysine in the amino acid sequence of a hepatitis C virus polyprotein and a polynucleotide coding for an NS4B protein, into a cell, the replicon-replicating cell can be prepared. By using the replicon-replicating cell, the screening for the drug can be carried out.
    • 本发明提供丙型肝炎病毒基因,来源于该基因的复制子RNA,引入复制子RNA的复制子复制细胞和使用复制子复制细胞筛选药物的方法。 通过引入包含(A)具有SEQ ID NO:5所示核酸序列的多核苷酸的复制子RNA; (B)具有SEQ ID NO:7所示核酸序列的多核苷酸; (C)编码具有SEQ ID NO:6所示氨基酸序列的多肽的多核苷酸; (D)编码具有SEQ ID NO:8所示氨基酸序列的多肽的多核苷酸; 或(E)具有与SEQ ID NO:5或SEQ ID NO:7所示核酸序列同源性不低于90%的核酸序列的多核苷酸; 或基因型1b的复制子RNA,其包含编码丙型肝炎病毒多蛋白的氨基酸序列中的第1804位氨基酸亮氨酸和第1966位氨基酸赖氨酸的核苷酸和编码NS4B蛋白的多核苷酸的复制子RNA, 可以制备复制细胞。 通过使用复制子复制细胞,可以进行药物的筛选。